Potentially inappropriate medication use among finnish non- institutionalized people aged ≥65 years: A register-based, cross-sectional, national study

Saija Leikola, Maarit Dimitrow, Alan Lyles, Kaisu Pitkälä, Marja Airaksinen

Research output: Contribution to journalArticle

Abstract

Background: The Beers criteria and their modifications are the most frequently used tools for measuring potentially inappropriate medication (PIM) use among older people. The prevalence of such use in various settings has been high, but no data have been reported for an entire national non- institutionalized elderly population, nor is there information on the reimbursement costs for those medications. Objective: To determine the prevalence of PIM use according to the Beers 2003 criteria, independent of diagnoses, among Finnish non-institutionalized people aged ≥65 years, and the reimbursement costs for these medications. Methods: A register-based cross-sectional national study used drug reimbursement data from Finland's Social Insurance Institution (SII). These data cover the entire non-institutionalized population aged ≥65 years in 2007. The number of persons who received reimbursements for each PIM according to the Beers 2003 criteria and the total annual reimbursement costs for PIMs were calculated. Indirect costs were excluded. Results: Of the non-institutionalized population aged ≥65 years in Finland (n=841509), 14.7% (n=123545) had received PIMs according to the Beers 2003 criteria. Temazepam >15mg/day was clearly the most commonly reimbursed PIM (4.4% of the population aged ≥65 years), followed by amitriptyline (2.0%) and diazepam (1.8%). The SII paid drug reimbursements of €2.9 million for PIMs, which was 0.7% of the total drug reimbursements (€421 million) for people aged ≥65 years in Finland in 2007. Conclusions: The use of PIMs among outpatients aged ≥65 years in Finland (14.7%) was less than in several earlier large-scale studies in other countries (17-42%) and reimbursement costs were modest, mainly as a result of the limited availability in Finland of medicines identified as PIMs by the Beers 2003 criteria. However, benzodiazepines were commonly used and actions to improve medication safety should target reducing their use.

Original languageEnglish (US)
Pages (from-to)227-236
Number of pages10
JournalDrugs & Aging
Volume28
Issue number3
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Cross-Sectional Studies
Finland
Costs and Cost Analysis
Social Security
Population
Pharmaceutical Preparations
Potentially Inappropriate Medication List
Amitriptyline
Temazepam
Diazepam
Benzodiazepines
Outpatients
Safety

Keywords

  • Benzodiazepines, therapeutic use
  • Drug-utilisation
  • Elderly
  • Prescribing

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Geriatrics and Gerontology

Cite this

Potentially inappropriate medication use among finnish non- institutionalized people aged ≥65 years : A register-based, cross-sectional, national study. / Leikola, Saija; Dimitrow, Maarit; Lyles, Alan; Pitkälä, Kaisu; Airaksinen, Marja.

In: Drugs & Aging, Vol. 28, No. 3, 2011, p. 227-236.

Research output: Contribution to journalArticle

Leikola, Saija ; Dimitrow, Maarit ; Lyles, Alan ; Pitkälä, Kaisu ; Airaksinen, Marja. / Potentially inappropriate medication use among finnish non- institutionalized people aged ≥65 years : A register-based, cross-sectional, national study. In: Drugs & Aging. 2011 ; Vol. 28, No. 3. pp. 227-236.
@article{bd86551c814a4ad6bb27c4c20524188b,
title = "Potentially inappropriate medication use among finnish non- institutionalized people aged ≥65 years: A register-based, cross-sectional, national study",
abstract = "Background: The Beers criteria and their modifications are the most frequently used tools for measuring potentially inappropriate medication (PIM) use among older people. The prevalence of such use in various settings has been high, but no data have been reported for an entire national non- institutionalized elderly population, nor is there information on the reimbursement costs for those medications. Objective: To determine the prevalence of PIM use according to the Beers 2003 criteria, independent of diagnoses, among Finnish non-institutionalized people aged ≥65 years, and the reimbursement costs for these medications. Methods: A register-based cross-sectional national study used drug reimbursement data from Finland's Social Insurance Institution (SII). These data cover the entire non-institutionalized population aged ≥65 years in 2007. The number of persons who received reimbursements for each PIM according to the Beers 2003 criteria and the total annual reimbursement costs for PIMs were calculated. Indirect costs were excluded. Results: Of the non-institutionalized population aged ≥65 years in Finland (n=841509), 14.7{\%} (n=123545) had received PIMs according to the Beers 2003 criteria. Temazepam >15mg/day was clearly the most commonly reimbursed PIM (4.4{\%} of the population aged ≥65 years), followed by amitriptyline (2.0{\%}) and diazepam (1.8{\%}). The SII paid drug reimbursements of €2.9 million for PIMs, which was 0.7{\%} of the total drug reimbursements (€421 million) for people aged ≥65 years in Finland in 2007. Conclusions: The use of PIMs among outpatients aged ≥65 years in Finland (14.7{\%}) was less than in several earlier large-scale studies in other countries (17-42{\%}) and reimbursement costs were modest, mainly as a result of the limited availability in Finland of medicines identified as PIMs by the Beers 2003 criteria. However, benzodiazepines were commonly used and actions to improve medication safety should target reducing their use.",
keywords = "Benzodiazepines, therapeutic use, Drug-utilisation, Elderly, Prescribing",
author = "Saija Leikola and Maarit Dimitrow and Alan Lyles and Kaisu Pitk{\"a}l{\"a} and Marja Airaksinen",
year = "2011",
doi = "10.2165/11586890-000000000-00000",
language = "English (US)",
volume = "28",
pages = "227--236",
journal = "Drugs and Aging",
issn = "1170-229X",
publisher = "Adis International Ltd",
number = "3",

}

TY - JOUR

T1 - Potentially inappropriate medication use among finnish non- institutionalized people aged ≥65 years

T2 - A register-based, cross-sectional, national study

AU - Leikola, Saija

AU - Dimitrow, Maarit

AU - Lyles, Alan

AU - Pitkälä, Kaisu

AU - Airaksinen, Marja

PY - 2011

Y1 - 2011

N2 - Background: The Beers criteria and their modifications are the most frequently used tools for measuring potentially inappropriate medication (PIM) use among older people. The prevalence of such use in various settings has been high, but no data have been reported for an entire national non- institutionalized elderly population, nor is there information on the reimbursement costs for those medications. Objective: To determine the prevalence of PIM use according to the Beers 2003 criteria, independent of diagnoses, among Finnish non-institutionalized people aged ≥65 years, and the reimbursement costs for these medications. Methods: A register-based cross-sectional national study used drug reimbursement data from Finland's Social Insurance Institution (SII). These data cover the entire non-institutionalized population aged ≥65 years in 2007. The number of persons who received reimbursements for each PIM according to the Beers 2003 criteria and the total annual reimbursement costs for PIMs were calculated. Indirect costs were excluded. Results: Of the non-institutionalized population aged ≥65 years in Finland (n=841509), 14.7% (n=123545) had received PIMs according to the Beers 2003 criteria. Temazepam >15mg/day was clearly the most commonly reimbursed PIM (4.4% of the population aged ≥65 years), followed by amitriptyline (2.0%) and diazepam (1.8%). The SII paid drug reimbursements of €2.9 million for PIMs, which was 0.7% of the total drug reimbursements (€421 million) for people aged ≥65 years in Finland in 2007. Conclusions: The use of PIMs among outpatients aged ≥65 years in Finland (14.7%) was less than in several earlier large-scale studies in other countries (17-42%) and reimbursement costs were modest, mainly as a result of the limited availability in Finland of medicines identified as PIMs by the Beers 2003 criteria. However, benzodiazepines were commonly used and actions to improve medication safety should target reducing their use.

AB - Background: The Beers criteria and their modifications are the most frequently used tools for measuring potentially inappropriate medication (PIM) use among older people. The prevalence of such use in various settings has been high, but no data have been reported for an entire national non- institutionalized elderly population, nor is there information on the reimbursement costs for those medications. Objective: To determine the prevalence of PIM use according to the Beers 2003 criteria, independent of diagnoses, among Finnish non-institutionalized people aged ≥65 years, and the reimbursement costs for these medications. Methods: A register-based cross-sectional national study used drug reimbursement data from Finland's Social Insurance Institution (SII). These data cover the entire non-institutionalized population aged ≥65 years in 2007. The number of persons who received reimbursements for each PIM according to the Beers 2003 criteria and the total annual reimbursement costs for PIMs were calculated. Indirect costs were excluded. Results: Of the non-institutionalized population aged ≥65 years in Finland (n=841509), 14.7% (n=123545) had received PIMs according to the Beers 2003 criteria. Temazepam >15mg/day was clearly the most commonly reimbursed PIM (4.4% of the population aged ≥65 years), followed by amitriptyline (2.0%) and diazepam (1.8%). The SII paid drug reimbursements of €2.9 million for PIMs, which was 0.7% of the total drug reimbursements (€421 million) for people aged ≥65 years in Finland in 2007. Conclusions: The use of PIMs among outpatients aged ≥65 years in Finland (14.7%) was less than in several earlier large-scale studies in other countries (17-42%) and reimbursement costs were modest, mainly as a result of the limited availability in Finland of medicines identified as PIMs by the Beers 2003 criteria. However, benzodiazepines were commonly used and actions to improve medication safety should target reducing their use.

KW - Benzodiazepines, therapeutic use

KW - Drug-utilisation

KW - Elderly

KW - Prescribing

UR - http://www.scopus.com/inward/record.url?scp=79951889939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951889939&partnerID=8YFLogxK

U2 - 10.2165/11586890-000000000-00000

DO - 10.2165/11586890-000000000-00000

M3 - Article

C2 - 21329402

AN - SCOPUS:79951889939

VL - 28

SP - 227

EP - 236

JO - Drugs and Aging

JF - Drugs and Aging

SN - 1170-229X

IS - 3

ER -